In managing neonatal hypotension, which statement best differentiates dopamine and dobutamine and identifies essential monitoring?

• A. Dobutamine is preferred for poor perfusion with high SVR; monitor BP, perfusion, urine output, and tachyarrhythmias.
• B. Dopamine is used for high cardiac output with vasodilation; monitor oxygen saturation.
• C. Dopamine for poor perfusion with high SVR; monitor BP, perfusion, heart rate, urine output, and signs of tachyarrhythmias.
• D. Dobutamine for low SVR and tachyarrhythmias; monitor glucose and respiratory rate.

Answer: (C)

In neonatal hypotension, the best approach depends on the patient’s hemodynamic pattern, specifically perfusion status and systemic vascular resistance. Dopamine is favored when there is poor perfusion with high SVR because it can both raise blood pressure and improve organ perfusion through dose-dependent actions that include inotropy and vasoconstriction at higher doses. Dobutamine, by contrast, is more of a beta-1 inotrope with some beta-2–mediated vasodilation, which tends to lower SVR and can drop blood pressure, making it less ideal when perfusion is poor and SVR is high.

Monitoring during vasoactive therapy is essential and should focus on indicators of perfusion and potential adverse effects. Track blood pressure and overall perfusion to see if organ blood flow improves, monitor heart rate because these drugs increase inotropy and can provoke tachycardia, keep an eye on urine output as a practical measure of renal perfusion and overall perfusion, and watch for signs of tachyarrhythmias from adrenergic stimulation. This combination of when to use dopamine and what to monitor aligns with the best approach for managing this scenario.